AUPH vs XEL · P/E 28, rev $160.9M vs P/E 20, $39.33B cap
Aurinia Pharmaceuticals Inc (AUPH) versus Xcel Energy Inc (XEL) — a side-by-side from cached financials, not a winner call.
Aurinia Pharmaceuticals Inc (AUPH) is a biotechnology company listed on US.
Xcel Energy Inc (XEL) is a utilities - regulated electric company listed on US.
Latest reported AUPH revenue for 2026-06-30 was $160.9M. Net income was $71.8M. AUPH currently screens at market cap $1.03B and trailing P/E 28.1.
XEL does not have a complete income-statement cache yet.
AUPH currently screens at market cap $1.03B and trailing P/E 28.1. XEL currently screens at market cap $39.33B and trailing P/E 20.1.
Not investment advice. Open the AUPH and XEL stock pages for the full models.
Not investment advice.